NTI Completed patient recruitment for its clinical trial for children with Autism
Neurotech International (ASX:NTI) completed patient recruitment for its Phase II/III NTIASD2 clinical trial for children with Autism. Patients recruited require substantial support and very substantial support autism | ASX Announcement: https://announcements.asx.com.au/asxpdf/20231219/pdf/05yq6fqpsynsvp.pdf #Autism #shorts
PLY agreement with Warner Bros.Interactive Entertainment
PlaySide Studios (ASX:PLY) announces the signing of a multi-game license agreement with Warner Bros. Interactive Entertainment to provide PLY with a highly recognisable intellectual property under license to develop two PC/Console game titles https://wcsecure.weblink.com.au/pdf/PLY/02753821.pdf #
TAH awarded a 20-year Victorian Wagering and Betting Licence
Tabcorp Holdings (ASX:TAH) has been awarded a 20-year Wagering and Betting Licence by the Victorian Government. The agreement removes Tabcorp’s Victorian Racing Industry joint venture and industry funding obligations | ASX Announcement: https://announcements.asx.com.au/asxpdf/20231218/pdf/05ynsb3wkg0b7y.pdf #Victoria #shorts
SRJ Signs Global Collaboration Agreement with Air Control Entech
SRJ Technologies Group (ASX:SRJ) signed a three-year Global Collaboration Agreement with UK-based specialised advanced robotic inspector Air Control Entech. The agreement creates a framework to develop new technologies for the energy sector and expand the global reach of both entities | https://announcements.asx.com.au/asxpdf/20231215/pdf/05ylfc2s55032r.pdf #UK #shorts
BOT successful completion of human factors validation study
Clinical dermatology company Botanix Pharmaceuticals (ASX:BOT) announces that the Company has successfully completed the planned human factors validation study assessing the revised Instructions for Use for Sofpironium Bromide gel https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02753854-6A1186430 #shorts
AGN on track for Phase 2 trials during CY24
Argenica Therapeutics (ASX:AGN) has completed the manufacturing of the ARG-007 drug required for Phase 2 clinical trials. The finalised, sterile drug product manufacturing will be completed by the end of the year keeping the Argenica on track for first patient dosing during Q1 CY24 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20231214/pdf/05yjzbqmnd1b00.pdf $AGN #Phase2 #ClinicalTrials #shorts
L1M Drilling contractor appointed
Lightning Minerals (ASX:L1M) reports appointment of Gyro Drilling Australia for its upcoming Aircore drill program planned to commence in January 2024 targeting high priority lithium in soil anomalism up to 218ppm Li1 | ASX announcement: https://clients3.weblink.com.au/pdf/L1M/02753786.pdf #L1M #shorts
RNE Collaborating with Mitsubishi Corporation subsidiary
ReNu Energy (ASX:RNE) has announced a collaboration with a subsidiary of the Mitsubishi Corporation to conduct studies for RNE’s green hydrogen project opportunity at Portland in Victoria. ReNu Energy and DGA will initially each have a 50% participating interest in the Project | ASX Announcement: https://announcements.asx.com.au/asxpdf/20231213/pdf/05yhrzy2zr9lfs.pdf #shorts
TTT Enters Partnerships
Titomic (ASX:TTT), a leading manufacturing technology company, announces a strategic manufacturing partnership agreement with Stärke Advanced Manufacturing Group (Stärke), a global, advanced manufacturer headquartered in South Australia https://yourir.info/resources/2daff4293b7634ea/announcements/ttt.asx/3A633039/TTT_Titomic_enters_Manufacturing_Partnership_Agreement.pdf #shorts
TNC confidently commits to restart mining at its Cloncurry Copper Project
True North Copper (ASX:TNC) announces that its Board has endorsed the Cloncurry Copper Project mining restart plan. In another important development, recent positive exploration and development outcomes across the Great Australia Mine Reserve and the Wallace North Resource has resulted in the Company’s decision to combine both projects as part of the mine | ASX […]